Literature DB >> 27825541

What is a better predictor of clinically relevant postoperative pancreatic fistula (CR-POPF) following pancreaticoduodenectomy (PD): postoperative day one drain amylase (POD1DA) or the fistula risk score (FRS)?

Kimberly A Bertens1, Angelena Crown1, Jesse Clanton1, Farzad Alemi1, Adnan A Alseidi1, Thomas Biehl1, William S Helton1, Flavio G Rocha2.   

Abstract

BACKGROUND: Both fistula risk score (FRS) and drain amylase in postoperative day 1 (POD1DA) have been promoted as tools to guide placement and removal of surgical drains following pancreaticoduodenectomy (PD). However, their individual utility has not been compared.
METHODS: A consecutive cohort of PD patients from 2013 to 2015 were identified from a prospectively collected institutional database. Pearson correlation coefficients and receiver operating characteristic (ROC) curves were calculated for FRS (negligible/low vs. moderate/high) and POD1DA of 600 U/L and 5000 U/L as predictors of clinically relevant postoperative pancreatic fistula (CR-POPF).
RESULTS: The incidence of CR-POPF was 27% in 216 patients. Sensitivity and specificity of FRS, POD1DA >600 U/L, and POD1DA >5000 U/L for predicting CR-POPF were 83% and 55%, 94% and 60%, 33% and 90%. The ROC area under the curve (AUC) for POD1DA >600 U/L (0.764) and FRS (0.749) were not significantly different (p = 0.713). However, POD1DA >5000 U/L (0.615) was significantly worse at predicting CR-POPF (p = 0.015). When FRS and POD1DA >600 U/L were combined; there was no improvement (p = 0.624). DISCUSSION: FRS and POD1DA are equally accurate in predicting CR-POPF. Patients with negligible/low FRS or POD1DA <600 U/L should be considered for drain removal.
Copyright © 2016 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27825541     DOI: 10.1016/j.hpb.2016.10.001

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  7 in total

1.  DRAIN AMYLASE ON THE FIRST POSTOPERATIVE DAY OF WHIPPLE SURGERY: WHAT VALUE IS THE BEST PREDICTOR FOR EARLY DRAIN REMOVAL?

Authors:  Enio Campos Amico; Ítalo Medeiros de Azevedo; Marcos Vinicius de Lira Fernandes; Mariane Albuquerque Reis; Samir Assi João
Journal:  Arq Bras Cir Dig       Date:  2018-03-01

Review 2.  Predictive value of drain pancreatic amylase concentration for postoperative pancreatic fistula on postoperative day 1 after pancreatic resection: An updated meta-analysis.

Authors:  Yao Liu; Yang Li; Ling Wang; Ci-Jun Peng
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

3.  Validation of original and alternative fistula risk scores in postoperative pancreatic fistula.

Authors:  Youngju Ryu; Sang Hyun Shin; Dae Joon Park; Naru Kim; Jin Seok Heo; Dong Wook Choi; In Woong Han
Journal:  J Hepatobiliary Pancreat Sci       Date:  2019-07-01       Impact factor: 7.027

4.  External validation of risk prediction platforms for pancreatic fistula after pancreatoduodenectomy using nomograms and artificial intelligence.

Authors:  So Jeong Yoon; Wooil Kwon; Ok Joo Lee; Ji Hye Jung; Yong Chan Shin; Chang-Sup Lim; Hongbeom Kim; Jin-Young Jang; Sang Hyun Shin; Jin Seok Heo; In Woong Han
Journal:  Ann Surg Treat Res       Date:  2022-03-04       Impact factor: 1.859

5.  C-reactive protein identifies patients at risk of postpancreatectomy hemorrhage.

Authors:  C Vilhav; J B Fagman; E Holmberg; P Naredi; C Engström
Journal:  Langenbecks Arch Surg       Date:  2022-03-20       Impact factor: 2.895

6.  Standardization of early drain removal following pancreatic resection: proposal of the "Ottawa pancreatic drain algorithm".

Authors:  Heather Smith; Fady K Balaa; Guillaume Martel; Jad Abou Khalil; Kimberly A Bertens
Journal:  Patient Saf Surg       Date:  2019-12-02

7.  Perioperative risk of pancreatic head resection-nomogram-based prediction of severe postoperative complications as a decisional aid for clinical practice.

Authors:  J Hipp; L Rist; S Chikhladze; D A Ruess; S Fichtner-Feigl; U A Wittel
Journal:  Langenbecks Arch Surg       Date:  2022-03-23       Impact factor: 2.895

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.